Arielle Ades
Family · Boulder, CONPI 1417625930
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Amgen at 24.2% of the total. 2025 is the largest year on record at $9,090, more than ten times the $265 reported in 2021. Among family clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $68.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- Arcutis Biotherapeutics, Inc.$2K
- Regeneron$1K
- E.r. Squibb & Sons, L.L.C.$1K
- Sanofi$1K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$730
- plus $4K from 17 others
What the payments were for
- Consulting fees$3,78930%
- Speaking & faculty fees$2,64121%
- Travel & lodging$270%
- Food & beverage$5,94048%
- Education$871%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 15 | $3,018 |
| Arcutis Biotherapeutics, Inc. | 19 | $1,630 |
| Regeneron | 4 | $1,359 |
| E.r. Squibb & Sons, L.L.C. | 3 | $1,024 |
| Sanofi | 16 | $1,007 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $730 |
| AbbVie | 18 | $675 |
| Johnson & Johnson | 15 | $654 |
| Lilly USA, LLC | 21 | $377 |
| Merz North America, Inc. | 2 | $349 |
| Pfizer | 20 | $311 |
| Regeneron Healthcare Solutions, Inc. | 8 | $249 |
| Journey Medical Corporation | 3 | $225 |
| Incyte Corporation | 8 | $172 |
| Novartis | 7 | $159 |
| Galderma Laboratories, L.p. | 4 | $138 |
| LEO Pharma Inc. | 2 | $125 |
| UCB, Inc. | 4 | $93 |
| Dermavant Sciences, Inc. | 1 | $87 |
| Verrica Pharmaceuticals Inc. | 2 | $45 |
| Boehringer Ingelheim | 1 | $22 |
| Organon | 2 | $19 |
| Sandoz | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,483 in reported general payments places this provider in the 95th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 15 | $235 |
Paid to pharmacies, not to this prescriber.
Other family in Boulder
- Allison GallowayBoulder$9K
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
- Katie NadingDenver$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.